Trials that use: Wald / z-test
2,196 results
- BLOCk-CTIIndependent statistical analysis of Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Body Mind Training Project: Complete Statistical AnalysisIndependent statistical analysis of Body Mind Training Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01564394).
- BOLTIndependent statistical analysis of A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- BOMPIndependent statistical analysis of Evaluation of a Millimeter Wave Emission Bracelet for Improving Parkinson's Disease Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Bone Wax Use for Hemostasis During Primary Unilateral Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Bone Wax Use for Hemostasis During Primary Unilateral Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- BOOST™Independent statistical analysis of Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BOTOX® Economic Spasticity Trial (BEST): Complete Statistical AnalysisIndependent statistical analysis of BOTOX® Economic Spasticity Trial (BEST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00549783).
- BOTOX® for the Treatment of Platysma Prominence: Complete Statistical AnalysisIndependent statistical analysis of BOTOX® for the Treatment of Platysma Prominence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03915067).
- Botulinum Toxin A to Treat Arm Tremor: Complete Statistical AnalysisIndependent statistical analysis of Botulinum Toxin A to Treat Arm Tremor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02207946).
- Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia: Complete Statistical AnalysisIndependent statistical analysis of Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Brain Stimulation and Enhancing Cognition in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Brain Stimulation and Enhancing Cognition in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03653351).
- Brain Training to Enhance Frontal Lobe Reasoning: Complete Statistical AnalysisIndependent statistical analysis of Brain Training to Enhance Frontal Lobe Reasoning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01552473).
- BRAiN-MIndependent statistical analysis of Bringing Relief to Adolescents Naturally Using Melatonin for Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02344316).
- BRAVE-EPAIndependent statistical analysis of Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02719327).
- BreastCAREIndependent statistical analysis of Breast Cancer Risk Reduction: A Patient Doctor Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01830933).
- BREEZE-AD1Independent statistical analysis of A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment: Complete Statistical AnalysisIndependent statistical analysis of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD): Complete Statistical AnalysisIndependent statistical analysis of Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control: Complete Statistical AnalysisIndependent statistical analysis of BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04365465).
- Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functioning Among Veterans: Complete Statistical AnalysisIndependent statistical analysis of Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functioning Among Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Brief Group Psychoeducation for Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Brief Group Psychoeducation for Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02911519).
- Brief Intervention for Justice-Involved Substance Users: Complete Statistical AnalysisIndependent statistical analysis of Brief Intervention for Justice-Involved Substance Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03308877).
- BRIGHT AML1019Independent statistical analysis of A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia: primary endpoint results, effect estimate…
- BROOKLYNIndependent statistical analysis of Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- BTX-A-HAC NGIndependent statistical analysis of Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Buccal Versus Vaginal Misoprostol for Third Trimester Induction of Labor: Complete Statistical AnalysisIndependent statistical analysis of Buccal Versus Vaginal Misoprostol for Third Trimester Induction of Labor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01519765).
- buffering SLNIndependent statistical analysis of Does Alkalinization Reduce Perceived Pain Levels During Sentinel Lymph Node Imaging?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Bundling and Unbundling the Laparoscopic Electrosurgery Cord With the Camera Cord: Complete Statistical AnalysisIndependent statistical analysis of Bundling and Unbundling the Laparoscopic Electrosurgery Cord With the Camera Cord: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01157169).
- Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00879996).
- Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04995029).
- Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Buspirone for Functional Dysphagia: Complete Statistical AnalysisIndependent statistical analysis of Buspirone for Functional Dysphagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02674412).
- BWP-ADIndependent statistical analysis of Enhancing Consent for Alzheimer's Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00453544).
- BWSP3Independent statistical analysis of Black Widow Spider Antivenin for Patients With Systemic Latrodectism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00657540).
- C-CADIndependent statistical analysis of Community-Based Communication Approaches for Blood Donation in Ghana: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04783077).
- C-earlyIndependent statistical analysis of A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve…
- C-RESULTSIndependent statistical analysis of Correcting Residual Errors With Spectral, Ultrasound, Traditional Speech Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03737318).
- C3POIndependent statistical analysis of Cerebral Perfusion Pressure Using Precedex and Other Sedatives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01169467).
- C7-T1 Epidural Steroid Injections Versus Targeted Injection for Treatment of Cervical Radicular Pain: Complete Statistical AnalysisIndependent statistical analysis of C7-T1 Epidural Steroid Injections Versus Targeted Injection for Treatment of Cervical Radicular Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CAESARIndependent statistical analysis of Candesartan Effect in Second Stage Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00621153).
- CAFIndependent statistical analysis of Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CAFETERIAIndependent statistical analysis of Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CALIPSOIndependent statistical analysis of CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Caminamos: A Smartphone App to Connect With Walking Partners: Complete Statistical AnalysisIndependent statistical analysis of Caminamos: A Smartphone App to Connect With Walking Partners: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03059901).
- CAMMPSIndependent statistical analysis of Comprehensive vs. Assisted Management of Mood and Pain Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01757301).
- Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?: Complete Statistical AnalysisIndependent statistical analysis of Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade?: Complete Statistical AnalysisIndependent statistical analysis of Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…